Jacques Pierre Moreau
Director/Board Member at Mulleris Therapeutics, Inc.
Jacques Pierre Moreau active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Mulleris Therapeutics, Inc. | Director/Board Member | - | - |
| Chondiothera, Inc. | Director/Board Member | - | - |
Career history of Jacques Pierre Moreau
Former positions of Jacques Pierre Moreau
| Companies | Position | Start | End |
|---|---|---|---|
Tercica, Inc.
 Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Director/Board Member | - | 2014-02-02 |
Phytomedics, Inc.
 Phytomedics, Inc. Pharmaceuticals: OtherHealth Technology Phytomedics, Inc. discovers, develops, and manufactures botanical therapeutics using proprietary platform technologies. The company was founded in December 1996 by Ilya Raskin and is headquartered in Jamesburg, NJ. | Director/Board Member | 2011-06-23 | 2012-12-02 |
ProteoThera, Inc.
 ProteoThera, Inc. Pharmaceuticals: MajorHealth Technology ProteoThera, Inc. is a biotechnology company that develops drug targeting technology. It offers transformative platform, a proprietary tissue matrix-binding protein fusion technology. The firm develops therapeutics to create a new paradigm in the treatment of auto inflammatory diseases and in tissue regeneration. The company was founded by Jacques P. Moreau, Parth Patwari, and Richard T. Lee and is headquartered in MA. | Director/Board Member | - | - |
| Chief Executive Officer | - | - | |
| Founder | - | - | |
| IPSEN | Chief Tech/Sci/R&D Officer | 1993-12-31 | - |
Biomeasure, Inc.
 Biomeasure, Inc. Pharmaceuticals: MajorHealth Technology Part of Ipsen SA, Biomeasure, Inc. researches, develops, and manufactures peptides and toxins for treating various conditions. The company is based in Milford, MA. The company was founded by Jacques Pierre Moreau. | Chief Executive Officer | 1976-09-30 | - |
| Founder | 1976-09-30 | - | |
| President | 1976-09-30 | - | |
| DR. REDDY'S LABORATORIES LIMITED | Director/Board Member | 2007-05-17 | - |
| Independent Dir/Board Member | 2011-06-23 | - |
Training of Jacques Pierre Moreau
| University of Orléans | Undergraduate Degree |
Statistics
International
| United States | 7 |
| India | 2 |
| France | 2 |
Operational
| Director/Board Member | 6 |
| Chief Executive Officer | 2 |
| Founder | 2 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| DR. REDDY'S LABORATORIES LIMITED | Health Technology |
| IPSEN | Health Technology |
| Private companies | 6 |
|---|---|
Tercica, Inc.
Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Health Technology |
Phytomedics, Inc.
Phytomedics, Inc. Pharmaceuticals: OtherHealth Technology Phytomedics, Inc. discovers, develops, and manufactures botanical therapeutics using proprietary platform technologies. The company was founded in December 1996 by Ilya Raskin and is headquartered in Jamesburg, NJ. | Health Technology |
Biomeasure, Inc.
Biomeasure, Inc. Pharmaceuticals: MajorHealth Technology Part of Ipsen SA, Biomeasure, Inc. researches, develops, and manufactures peptides and toxins for treating various conditions. The company is based in Milford, MA. The company was founded by Jacques Pierre Moreau. | Health Technology |
| Mulleris Therapeutics, Inc. | |
| Chondiothera, Inc. | |
ProteoThera, Inc.
ProteoThera, Inc. Pharmaceuticals: MajorHealth Technology ProteoThera, Inc. is a biotechnology company that develops drug targeting technology. It offers transformative platform, a proprietary tissue matrix-binding protein fusion technology. The firm develops therapeutics to create a new paradigm in the treatment of auto inflammatory diseases and in tissue regeneration. The company was founded by Jacques P. Moreau, Parth Patwari, and Richard T. Lee and is headquartered in MA. | Health Technology |
